Binder G M
Amgen, One Amgen Center Drive, Thousand Oaks, CA 91320-1789, USA.
Curr Opin Biotechnol. 1999 Jun;10(3):303-6. doi: 10.1016/S0958-1669(99)80054-8.
The FDA Modernization Act of 1997 represents a notable public policy achievement that was conceived not out of crisis, but rather out of a shared commitment that the FDA can both protect patient health (by assuring drugs are safe and effective) and promote public health (by being given additional resources and new procedural efficiencies to accelerate the review of applications for new medicines). The FDA is conscientiously implementing this important new law, but there are areas where more work is required. On balance, the prospects are that this law will help usher in a much improved era for patients.
1997年的《美国食品药品监督管理局现代化法案》是一项显著的公共政策成就,它并非因危机而产生,而是源于一种共同的信念,即美国食品药品监督管理局既能(通过确保药品安全有效)保护患者健康,又能(通过获得更多资源和新的程序效率来加速新药申请审查)促进公众健康。美国食品药品监督管理局正在认真执行这项重要的新法律,但仍有一些领域需要进一步努力。总体而言,这项法律有望为患者带来一个大为改善的时代。